N
ARMP icon

Nuveen’s Armata Pharmaceuticals ARMP Stock Holding History

Nuveen’s Portfolio ARMP Stock Details ARMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$103K Buy
+15,905
New +$146K ﹤0.01% 3706

Other funds holding ARMP

MAM
Madison Asset Management Madison, Wisconsin $8.39B AUM 16.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GWM
GSB Wealth Management Guilford, Connecticut $498M AUM 27.51% 1-Year Est. Return
SWM
SeaCrest Wealth Management Purchase, New York $903M AUM 47.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Nuveen's ARMP Position: Q2 2026 in Review

Nuveen opened a new position in Armata Pharmaceuticals (ARMP) in Q2 2026: 15,905 shares worth $103K. The stake represents ﹤0.01% of the portfolio and ranks #3706 among its holdings.

22 funds tracked by Wall St. Rank hold ARMP as of Q2 2026.

  • Nuveen held 15,905 shares of Armata Pharmaceuticals worth $103K as of Q2 2026.
  • Armata Pharmaceuticals was a new Nuveen position in Q2 2026.
  • Armata Pharmaceuticals made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #3706 holding.
  • 22 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.